- Home
- ENVB vs BYAH Comparison
ENVB vs BYAH Comparison
Compare ENVB & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENVB | BYAH |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | China |
| Employees | N/A | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.5M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENVB | BYAH |
|---|---|---|
| Price | $3.39 | $1.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.8M | 11.5K |
| Earning Date | 05-14-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,914,675.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $0.05 |
| 52 Week High | $13.25 | $2.77 |
Technical Indicators
Market Signals| Indicator | ENVB | BYAH |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 57.47 |
| Support Level | $1.22 | $0.93 |
| Resistance Level | $4.48 | $2.77 |
| Average True Range (ATR) | 1.07 | 0.06 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 27.36 | 92.93 |
Price Performance
Historical ComparisonAbout ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.